Abstract
In our study we monitor the gonadotopin therapy by ultrasound because serum oestradiol is not available in Basrah, and we investigate whether pelvic ultrasound alone suffices to control ovarian response to gonadotropin to induce ovulation. Real time ultrasound scanning of follicular development was performed for 35 patients receiving metrodin during 113 cycle. Twenty pregnancies were obtained resulting in a pregnancy rate of (57.1%); with (16) patients singletons, set of twins 4 (20%), with abortions 6(30%) and about patients 2 (5%) develops mild ovarian hyperstimulation syndrome (OHSS). So ultrasound alone can be used effectively to control gonadotropin therapy in the majority of cases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
